Ulcerative Colitis Clinical Trials in Cincinnati, Ohio

4 studies are recruiting for ulcerative colitis in Cincinnati, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 month…

    Stage
    Phase 4
    Ages
    18 to 80
    Site
    Gastro Health Research - Cincinnati, Cincinnati, Ohio
    Locations
    101 in total
    Run by
    Takeda

    See if you can join NCT06581328 on ClinicalTrials.gov

  2. A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

    The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim is to learn about treatment with Vedolizumab alone after the double treatment. All participants wi…

    Stage
    Phase 4
    Ages
    18 to 65
    Site
    University of Cincinnati, Cincinnati, Ohio
    Locations
    46 in total
    Run by
    Takeda

    See if you can join NCT06095128 on ClinicalTrials.gov

  3. A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

    The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severely active ulcerative colitis (UC).

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    GCGA Physicians, LLC dba / Gastro Health Research, Cincinnati, Ohio
    Locations
    207 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06598943 on ClinicalTrials.gov

  4. Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

    The goal of this observational study is to assess the feasibility and effectiveness of a remote monitoring digital health system on adherence, clinical outcomes, and healthcare utilization in patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis, and inflammatory bowel disea…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Cincinnati, Cincinnati, Ohio
    Locations
    6 in total
    Run by
    Mercy Medical Center

    See if you can join NCT06750731 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.